Over the next five years, a pilot study at the U.S. National Institutes of Health will test the use of stem cells from blood as a therapy for people with severe cases of lupus, a disease in which a person’s immune system attacks the body’s cells and tissues. People with lupus may experience inflammation, joint pain and, in some cases, damage to major organs.
